Gourdin concentrates his practice on intellectual property litigation with a particular emphasis on biopharmaceutical patent disputes. His experience spans diverse industries, including life sciences, technology, and financial services.

Gourdin effectively represents clients in complex legal disputes ranging from large pharmaceutical cases under the Biologics Price Competition and Innovation Act and Hatch-Waxman Act to intricate patent issues involving diagnostic testing products, electronics, software, microelectromechanical systems, telecommunications systems, and innovative financial products. He also regularly litigates on behalf of clients with approved FDA biological products as well as prospective generic or biosimilar entrants, in both biologic and small molecule cases.

A seasoned trial lawyer, Gourdin excels in all phases of the litigation process, including pre-trial procedures, motion practice, and Markman hearings. He is skilled in fact and expert discovery, depositions, case strategy development, motion practice, and licensing and settlement negotiations. Beyond his core focus, Gourdin’s legal practice additionally spans a range of areas, including pro bono, immigration, bankruptcy, toxic torts, employment litigation, and complex commercial disputes. He also advises on campaign finance compliance and other election-related legal matters at both the state and federal levels.

Prior to joining Mintz, Gourdin was an associate at an international law firm, where he worked on a broad spectrum of litigation.